临床实践指南:鼻整形术后改善鼻腔形态与功能
该指南由指南制定小组制定,针对≥15岁鼻整形患者提出围手术期管理推荐。推荐包括评估手术动机与期望、筛查合并症、术前评估鼻气道阻塞、患者教育、睡眠呼吸暂停咨询、术后不适管理及术后至少12个月满意度记录;反对术后常规使用抗生素超过24小时及常规鼻腔填塞;可考虑围手术期全身激素。
要点
- 术前应询问手术动机与期望并记录讨论,评估合并症如阻塞性睡眠呼吸暂停、躯体变形障碍等。
- 术前应评估鼻气道阻塞,教育术后预期、并发症及可能需再次鼻部手术。
- 反对术后常规抗生素超过24小时及常规鼻腔填塞;可考虑围手术期全身激素。
核心结论
- 指南旨在为鼻整形患者提供循证推荐,优化患者安全与手术效果,减少有害或不必要的医疗差异。
研究设计与样本
- 指南制定小组制定,目标人群为所有年龄≥15岁的鼻整形患者,目标受众为参与管理的临床医生。
主要发现
- 2014年美国报告鼻整形手术超过200000例,平均手术费用通常超过4000美元。
- 指南就术前评估、患者教育、术后管理及满意度记录等提出7条推荐,并反对2项常规做法,另给出1项可选措施。
关键数值与推荐
- 推荐:所有寻求鼻整形的患者应被询问手术动机与结果期望,提供期望是否现实的反馈,并记录讨论。
- 推荐:评估合并症如阻塞性睡眠呼吸暂停、躯体变形障碍、出血性疾病或长期使用局部血管收缩性鼻内药物。
- 推荐:术前评估鼻气道阻塞,并教育术后预期、对鼻呼吸的影响、并发症及未来可能需鼻部手术。
- 推荐:对确诊阻塞性睡眠呼吸暂停者咨询手术对鼻气道阻塞的影响及围手术期管理。
- 推荐:术前教育术后不适管理策略,术后至少12个月记录患者对鼻外观和功能的满意度。
临床怎么用
- 临床应围绕术前动机评估、合并症筛查、鼻气道评估、患者教育及术后满意度记录开展鼻整形管理。
- 围手术期抗生素使用不应超过术后24小时,手术结束时不应常规鼻腔填塞。
- 可考虑围手术期全身激素,但为可选措施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Rhinoplasty, a surgical procedure that alters the shape or appearance of the nose while preserving or enhancing the nasal airway, ranks among the most commonly performed cosmetic procedures in the United States, with >200,000 procedures reported in 2014. While it is difficult to calculate the exact economic burden incurred by rhinoplasty patients following surgery with or without complications, the average rhinoplasty procedure typically exceeds $4000. The costs incurred due to complications, infections, or revision surgery may include the cost of long-term antibiotics, hospitalization, or lost revenue from hours/days of missed work. The resultant psychological impact of rhinoplasty can also be significant. Furthermore, the health care burden from psychological pressures of nasal deformities/aesthetic shortcomings, surgical infections, surgical pain, side effects from antibiotics, and nasal packing materials must also be considered for these patients. Prior to this guideline, limited literature existed on standard care considerations for pre- and postsurgical management and for standard surgical practice to ensure optimal outcomes for patients undergoing rhinoplasty. The impetus for this guideline is to utilize current evidence-based medicine practices and data to build unanimity regarding the peri- and postoperative strategies to maximize patient safety and to optimize surgical results for patients. Purpose The primary purpose of this guideline is to provide evidence-based recommendations for clinicians who either perform rhinoplasty or are involved in the care of a rhinoplasty candidate, as well as to optimize patient care, promote effective diagnosis and therapy, and reduce harmful or unnecessary variations in care. The target audience is any clinician or individual, in any setting, involved in the management of these patients. The target patient population is all patients aged ≥15 years. The guideline is intended to focus on knowledge gaps, practice variations, and clinical concerns associated with this surgical procedure; it is not intended to be a comprehensive reference for improving nasal form and function after rhinoplasty. Recommendations in this guideline concerning education and counseling to the patient are also intended to include the caregiver if the patient is <18 years of age. Action Statements The Guideline Development Group made the following recommendations: (1) Clinicians should ask all patients seeking rhinoplasty about their motivations for surgery and their expectations for outcomes, should provide feedback on whether those expectations are a realistic goal of surgery, and should document this discussion in the medical record. (2) Clinicians should assess rhinoplasty candidates for comorbid conditions that could modify or contraindicate surgery, including obstructive sleep apnea, body dysmorphic disorder, bleeding disorders, or chronic use of topical vasoconstrictive intranasal drugs. (3) The surgeon, or the surgeon's designee, should evaluate the rhinoplasty candidate for nasal airway obstruction during the preoperative assessment. (4) The surgeon, or the surgeon's designee, should educate rhinoplasty candidates regarding what to expect after surgery, how surgery might affect the ability to breathe through the nose, potential complications of surgery, and the possible need for future nasal surgery. (5) The clinician, or the clinician's designee, should counsel rhinoplasty candidates with documented obstructive sleep apnea about the impact of surgery on nasal airway obstruction and how obstructive sleep apnea might affect perioperative management. (6) The surgeon, or the surgeon's designee, should educate rhinoplasty patients before surgery about strategies to manage discomfort after surgery. (7) Clinicians should document patients' satisfaction with their nasal appearance and with their nasal function at a minimum of 12 months after rhinoplasty. The Guideline Development Group made recommendations against certain actions: (1) When a surgeon, or the surgeon's designee, chooses to administer perioperative antibiotics for rhinoplasty, he or she should not routinely prescribe antibiotic therapy for a duration >24 hours after surgery. (2) Surgeons should not routinely place packing in the nasal cavity of rhinoplasty patients (with or without septoplasty) at the conclusion of surgery. The panel group made the following statement an option: (1) The surgeon, or the surgeon's designee, may administer perioperative systemic steroids to the rhinoplasty patient.
引用
- Ishii LE, Tollefson TT, Basura GJ, et al. Clinical Practice Guideline: Improving Nasal Form and Function after Rhinoplasty. Otolaryngol Head Neck Surg. 2017. PMID: 28145823. doi:10.1177/0194599816683153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。